General Information of the Compound
Compound ID
CP0044060
Compound Name
4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide
    Show/Hide
Synonyms
BI 2536
BI2536, BI 2536
    Show/Hide
Structure
Formula
C28H39N7O3
Molecular Weight
521.666
Canonical SMILES
CC[C@H]1N(C2CCCC2)c2nc(Nc3ccc(cc3OC)C(=O)NC3CCN(C)CC3)ncc2N(C)C1=O
    Show/Hide
InChI
InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1
    Show/Hide
InChIKey
XQVVPGYIWAGRNI-JOCHJYFZSA-N
CAS
755038-02-9
Physicochemical Property
logP
3.5568
Rotatable Bonds
7
Heavy Atom Count
38
Polar Areas
102.93
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
8
Complexity
38

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11364421
SID: 16456896
ChEMBL ID
CHEMBL513909
DrugBank ID
DB16107
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01203, ALK tyrosine kinase receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 890 nM
   TI
   LI
   LO
   TS
CL000727 Kelly Homo sapiens (Human)  1
1
IC50 > 9400 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 180 nM
2 IC50 = 390 nM
3 Kd = 160 nM
Protein ID: PT01462, Bromodomain-containing protein 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 1.2 nM
2 IC50 = 25 nM
3 IC50 = 150 nM
4 IC50 = 184 nM
5 IC50 = 205 nM
6 Kd = 37 nM
7 Kd = 87 nM
Protein ID: PT01252, Serine/threonine-protein kinase PLK1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 0.22 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 0.083 nM
2 IC50 = 0.8 nM
3 IC50 = 0.83 nM
4 IC50 < 2.6 nM
5 IC50 = 4 nM
6 IC50 = 8 nM
7 IC50 = 106 nM
8 Kd = 0.19 nM
9 Ki = 3 nM
Cell Viability or Cytotoxicity Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000091 MV4-11 Homo sapiens (Human)  1
1
GI50 = 15.2 nM
   TI
   LI
   LO
   TS
CL000111 MDA-MB-231 Homo sapiens (Human)  1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
CL000714 MM1.S Homo sapiens (Human)  1
1
IC50 = 1 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( BI 2536 )
Drug Name BI 2536
Company Boehringer Ingelheim
Indication
Acute myeloid leukaemia
Phase 2
Target(s)
Polo-like kinase 1 (PLK1)
Inhibitor